Skip to main content
. 2007 Oct 8;65(4):548–557. doi: 10.1111/j.1365-2125.2007.03039.x

Figure 3.

Figure 3

Evaluation of the final model: comparison between the 5th (dash line), 50th (full line) and 95th (dash line) percentile obtained from 1000 simulations and the observed data (points) for nelfinavir (top) and M8 (bottom)